Lung inflammation, injury, and proliferative response after repetitive particulate hexavalent chromium exposure

Environmental Health Perspectives

Volumn 117, Issue 12, 2009, Pages 1896-1902

  Beaver, Laura M ^a,b   Stemmy, Erik J ^a   Schwartz, Arnold M ^a   Damsker, Jesse M ^a   Constant, Stephanie L ^a   Ceryak, Susan M ^a   Patierno, Steven R ^a  

^a GEORGE WASHINGTON UNIVERSITY MEDICAL CENTER   (United States)

^b OREGON STATE UNIVERSITY   (United States)

Author keywords

Chromium; Hexavalent; Inflammation; Injury; Intranasal; Lung; Proliferation; Repair

Indexed keywords

CHROMIC ACID; CHROMIUM; GELATINASE B; KI 67 ANTIGEN; PROTEIN KINASE B; SODIUM CHLORIDE;

AIRWAY; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; EPITHELIUM CELL; FEMALE; HISTOLOGY; IMMUNOHISTOCHEMISTRY; INTERSTITIAL PNEUMONIA; LUNG INJURY; LUNG LAVAGE; LYMPHOCYTE; MACROPHAGE; MOUSE; NEUTROPHIL; NONHUMAN; PNEUMONIA; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; SURVIVAL;

ANIMALS; CELL PROLIFERATION; CHROMIUM; CHRONIC DISEASE; FEMALE; LUNG; MACROPHAGES; MATRIX METALLOPROTEINASE 9; MICE; MICE, INBRED BALB C; NEUTROPHIL INFILTRATION; PHOSPHORYLATION; PNEUMONIA; PROTO-ONCOGENE PROTEINS C-AKT; SIGNAL TRANSDUCTION;

ANIMALIA; MUS;

EID: 75349113683     PISSN: 00916765     EISSN: 15529924     Source Type: Journal    
DOI: 10.1289/ehp.0900715     Document Type: Article

References (47)

1. Albini A, Sporn MB. 2007. The tumour microenvironment as a target for chemoprevention. Nat Rev Cancer 7:139-147.
2. Altomare DA, Testa JR. 2005. Perturbations of the AKT signaling pathway in human cancer. Oncogene 24:7455-7464.
3. American Cancer Society. 2008. Cancer Facts & Figures 2008. Atlanta, GA:American Cancer Society. Available: http://www.cancer.org/docroot/stt/ content/stt-1x-cancer-facts-and-figures-2008.asp [accessed 29 October 2009].
4. Antonini JM, Stone S, Roberts JR, Chen B, Schwegler-Berry D, Afshari AA, et al. 2007. Effect of short-term stainless steel welding fume inhalation exposure on lung inflammation, injury, and defense responses in rats. Toxicol Appl Pharmacol 223:234-245.
5. ATSDR. 2000. Toxicological Profile for Chromium. Atlanta, GA:Agency for Toxic Substances and Disease Registry.
6. Azad N, Rojanasakul Y, Vallyathan V. 2008. Inflammation and lung cancer: roles of reactive oxygen/nitrogen species. J Toxicol Environ Health B Crit Rev 11:1-15.
7. Balansky RM, D'Agostini F, De Flora S. 1999. Induction, persistence and modulation of cytogenetic alterations in cells of smoke-exposed mice. Carcinogenesis 20:1491-1497.
8. Beaver LM, Stemmy EJ, Constant SL, Schwartz A, Little LG, Gigley J, et al. 2009. Lung injury, inflammation and Akt signaling following inhalation of particulate hexavalent chromium. Toxicol Appl Pharmacol 235:47-56.
9. Bellacosa A, Testa JR, Staal SP, Tsichlis PN. 1991. A retroviral oncogene, Akt, encoding a serine-threonine kinase containing an SH2-like region. Science 254:274-277.
10. Chapman SJ, Cookson WO, Musk AW, Lee, YC. 2003. Benign asbestos pleural diseases. Curr Opin Pulm Med 9:266-271.
11. Cohen MD, Zelikoff JT, Chen LC, Schlesinger RB. 1998. Immunotoxicologic effects of inhaled chromium: role of particle solubility and co-exposure to ozone. Toxicol Appl Pharmacol 152:30-40.
12. Coussens LM, Werb Z. 2002. Inflammation and cancer. Nature 420:860-867.
13. Eming SA, Krieg T, Davidson JM. 2007. Inflammation in wound repair: molecular and cellular mechanisms. J Invest Dermatol 127:514-525.
14. Federico A, Morgillo F, Tuccillo C, Ciardiello F, Loguercio, C. 2007. Chronic inflammation and oxidative stress in human carcinogenesis. Int J Cancer 121:2381-2386.
15. Fishbein L. 1981. Sources, transport and alterations of metal compounds: an overview. I. Arsenic, beryllium, cadmium, chromium, and nickel. Environ Health Perspect 40:43-64.
16. Freeman CM, Curtis JL, Chensue SW. 2007. CC chemokine receptor 5 and CXC chemokine receptor 6 expression by lung CD8+ cells correlates with chronic obstructive pulmonary disease severity. Am J Pathol 171:767-776.
17. Glaser U, Hochrainer D, Kloppel H, Kuhnen H. 1985. Low level chromium (VI) inhalation effects on alveolar macrophages and immune functions in Wistar rats. Arch Toxicol 57:250-256.
18. Hanahan D, Weinberg RA. 2000. The hallmarks of cancer. Cell 100:57-70.
19. IARC (International Agency for Research on Cancer). 1990. Chromium, nickel and welding. IARC Monogr Eval Carcinog Risks Hum 49:1-648.
20. Ishikawa Y, Nakagawa K, Satoh Y, Kitagawa T, Sugano H, Hirano T, et al. 1994. "Hot spots" of chromium accumulation at bifurcations of chromate workers' bronchi. Cancer Res 54:2342-2346.
21. Khuder SA, Herial NA, Mutgi AB, Federman DJ. 2005. Nonsteroidal antiinflammatory drug use and lung cancer: a metaanalysis. Chest 127:748-754.
22. Kim JH, Suk MH, Yoon DW, Lee SH, Hur GY, Jung KH, et al. 2006. Inhibition of matrix metalloproteinase-9 prevents neutrophilic inflammation in ventilator-induced lung injury. Am J Physiol Lung Cell Mol Physiol 291:L580-L587.
23. Lai JP, Dalton JT, Knoell DL. 2007. Phosphatase and tensin homologue deleted on chromosome ten (PTEN) as a molecular target in lung epithelial wound repair. Br J Pharmacol 152:1172-1184.
24. Li LF, Liao SK, Lee CH, Huang CC, Quinn DA. 2007. Involvement of Akt and endothelial nitric oxide synthase in ventilation-induced neutrophil infiltration: a prospective, controlled animal experiment. Crit Care 11:R89; doi:10.1186/cc6101 [Online 23 August 2007].
25. Lin WW, Karin M. 2007. A cytokine-mediated link between innate immunity, inflammation, and cancer. J Clin Invest 117:1175-1183.
26. Mossman BT, Churg A. 1998. Mechanisms in the pathogenesis of asbestosis and silicosis. Am J Respir Crit Care Med 157:1666-1680.
27. Nicholson AG, Wotherspoon AC, Diss TC, Hansell DM, Du BR, Sheppard MN, et al. 1995. Reactive pulmonary lymphoid disorders. Histopathology 26:405-412.
28. O'Brien TJ, Ceryak S, Patierno SR. 2003. Complexities of chromium carcinogenesis: role of cellular response, repair and recovery mechanisms. Mutat Res 533:3-36.
29. O'Hara KA, Klei LR, Barchowsky A. 2003. Selective activation of Src family kinases and JNK by low levels of chromium(VI). Toxicol Appl Pharmacol 190:214-223.
30. Oller AR. 2002. Respiratory carcinogenicity assessment of soluble nickel compounds. Environ Health Perspect 110:841-844.
31. Ray P, Devaux Y, Stolz DB, Yarlagadda M, Watkins SC, Lu Y, et al. 2003. Inducible expression of keratinocyte growth factor (KGF) in mice inhibits lung epithelial cell death induced by hyperoxia. Proc Natl Acad Sci USA 100:6098-6103.
32. Salehi F, Zayed J, Audusseau S, Muller C, Truchon G, Plamondon P, et al. 2009. Immunological responses in C3H/ HeJ mice following nose-only inhalation exposure to different sizes of beryllium metal particles. J Appl Toxicol 29:61-68.
33. Santillan AA, Camargo CA, Colditz GA. 2003. A meta-analysis of asthma and risk of lung cancer (United States). Cancer Causes Control 14:327-334.
34. Solano-Lopez C, Zeidler-Erdely PC, Hubbs AF, Reynolds SH, Roberts JR, Taylor MD, et al. 2006. Welding fume exposure and associated inflammatory and hyperplastic changes in the lungs of tumor susceptible A/J mice. Toxicol Pathol 34:364-372.
35. Steffee CH, Baettjer AM. 1965. Histopathologic effects of chromate chemicals. Arch Environ Health 11:66-75.
36. Steinhoff D, Gad SC, Hatfield GK, Mohr U. 1986. Carcinogenicity study with sodium dichromate in rats. Exp Pathol 30:129-141.
37. Suda T, Chida K, Hayakawa H, Imokawa S, Iwata M, Nakamura H, et al. 1999. Development of bronchus-associated lymphoid tissue in chronic hypersensitivity pneumonitis. Chest 115:357-363.
38. Svineng G, Ravuri C, Rikardsen O, Huseby NE, Winberg JO. 2008. The role of reactive oxygen species in integrin and matrix metalloproteinase expression and function. Connect Tissue Res 49:197-202.
39. Tan RJ, Fattman CL, Niehouse LM, Tobolewski JM, Hanford LE, Li Q, et al. 2006. Matrix metalloproteinases promote inflammation and fibrosis in asbestos-induced lung injury in mice. Am J Respir Cell Mol Biol 35:289-297.
40. Taylor MD, Roberts JR, Leonard SS, Shi X, Antonini JM. 2003. Effects of welding fumes of differing composition and solubility on free radical production and acute lung injury and inflammation in rats. Toxicol Sci 75:181-191.
41. Tsurutani J, Fukuoka J, Tsurutani H, Shih JH, Hewitt SM, Travis WD, et al. 2006. Evaluation of two phosphorylation sites improves the prognostic significance of Akt activation in non-small-cell lung cancer tumors. J Clin Oncol 24:306-314.
42. Turner MC, Chen Y, Krewski D, Calle EE, Thun, MJ. 2007. Chronic obstructive pulmonary disease is associated with lung cancer mortality in a prospective study of never smokers. Am J Respir Crit Care Med 176:285-290.
43. Van Dyke AL, Cote ML, Prysak G, Claeys GB, Wenzlaff AS, Schwartz AG. 2008. Regular adult aspirin use decreases the risk of non-small cell lung cancer among women. Cancer Epidemiol Biomarkers Prev 17:148-157.
44. Wallenborn JG, Evansky P, Shannahan JH, Vallanat B, Ledbetter AD, Schladweiler MC, et al. 2008. Subchronic inhalation of zinc sulfate induces cardiac changes in healthy rats. Toxicol Appl Pharmacol 232:69-77.
45. World Health Organization. 2002. Chapter 4. Quantifying selected major risks to health. In: The World Health Report 2002: Reducing Risks, Promoting Healthy Life. Geneva:World Health Organization, 47-97. Available: http://www.who.int/whr/2002/en/ [accessed 29 October 2009].
46. Yang P, Bamlet WR, Sun Z, Ebbert JO, Aubry MC, Krowka MJ, et al. 2005. Alpha1-antitrypsin and neutrophil elastase imbalance and lung cancer risk. Chest 128:445-452.
47. Zeidler-Erdely PC, Kashon ML, Battelli LA, Young SH, Erdely A, Roberts JR, et al. 2008. Pulmonary inflammation and tumor induction in lung tumor susceptible A/J and resistant C57BL/6J mice exposed to welding fume. Part Fibre Toxicol 5:12; doi:10.1186/1743-8977-5-12 [published 8 September 2008].